The megabillion-dollar buyout of Life Technologies (UNKNOWN:LIFE.DL) by Thermo Fisher Scientific (NYSE:TMO) grabbed a lot of headlines earlier this week. Fool contributor Rich Smith, however, has a different story to tell.
It's the story of one overpriced company buying another company that's an even worse bargain, which resulted in a medical equipment behemoth that's even more egregiously overpriced than the two companies were separately.
Fool contributor Rich Smith has no position in any stocks mentioned. The Motley Fool recommends Thermo Fisher Scientific. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
